Discontinuation of European vaccines can have unintended consequences
Meanwhile, Britain’s health regulator, which has so far fired 11 million shots of the AstraZeneca vaccine, far more than any other country, says no evidence that this vaccine carries a higher health risk.
But conflicting messages about how serious these reports are, and therefore how dangerous the vaccine is, have left people worried and confused by what is happening. Some experts are concerned that the news could undermine widespread efforts to achieve coronary inoculation.
“We don’t have much to follow because the government is making statements, but no data is being provided,” says Michael Head, chief global health researcher at Southampton University in the UK. “Germany seems to have a very high risk of having thrombosis … but I don’t see any data that suggests we should pause.”
One of the factors of the interruption, he suggested, is that Europe may still be in the early stages of the spread of vaccines, which means that some of those currently receiving doses may be among the most vulnerable or most at risk of medical problems. AstraZeneca says its research shows that they coagulate incidents they are lower than might be expected among the general population.
The situation plays into a broader narrative of vaccine risk. Many European countries have a high level of doubt about vaccines—A study in France suggested only 40% many people were planning to get vaccinated against covid-19 and the AstraZeneca vaccine in particular has sparked more concern and speculation than others.